Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development.
about
A phenotypic mouse model of basaloid breast tumorsCharacterization of receptors for murine pregnancy specific glycoproteins 17 and 23The niche factor syndecan-1 regulates the maintenance and proliferation of neural progenitor cells during mammalian cortical developmentAssociation of loss of epithelial syndecan-1 with stage and local metastasis of colorectal adenocarcinomas: an immunohistochemical study of clinically annotated tumors.Endometrial cells get side-tracked: side population cells promote epithelial-mesenchymal transition in endometrial carcinoma.FGF signaling sustains the odontogenic fate of dental mesenchyme by suppressing β-catenin signalingSyndecan-1 is required to maintain intradermal fat and prevent cold stress.Syndecan-1 knock-down in decidualized human endometrial stromal cells leads to significant changes in cytokine and angiogenic factor expression patterns.Aligned collagen is a prognostic signature for survival in human breast carcinomaHeparan sulfate proteoglycans.Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling.Enhanced efficacy and specificity of epithelial ovarian carcinogenesis by embedding a DMBA-coated cloth strip in the ovary of rat.Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.Loss of syndecan-1 is associated with malignant conversion in skin carcinogenesis.Ionizing radiation-mediated premature senescence and paracrine interactions with cancer cells enhance the expression of syndecan 1 in human breast stromal fibroblasts: the role of TGF-β.Thermogenic profiling using magnetic resonance imaging of dermal and other adipose tissuesMechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion.The signaling mechanisms of syndecan heparan sulfate proteoglycans.Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathwaysMicroRNA regulation of proteoglycan function in cancer.A cytoplasmic C-terminal fragment of Syndecan-1 is generated by sequential proteolysis and antagonizes Syndecan-1 dependent lung tumor cell migration.Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism.Primary dermal fibroblasts derived from sdc-1 deficient mice migrate faster and have altered alphav integrin function.The role for decorin in delayed-type hypersensitivityAlterations in Corneal Sensory Nerves During Homeostasis, Aging, and After Injury in Mice Lacking the Heparan Sulfate Proteoglycan Syndecan-1.Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases.The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium
P2860
Q28480588-D8444EFC-FB48-493C-8D39-C952EA237250Q28512753-533AE433-D27D-4EAC-9E67-B45BAB550F9AQ31088269-6A50C578-52FF-4B80-80F7-6AB32F190E21Q33347864-8F19A635-8D54-4072-A383-9CBF9CED8D20Q33556199-97DC89C3-EF97-49F1-98BC-CE8F90DC3DBAQ33557428-0CC73954-0013-49C2-A06B-52F51E3FBBE6Q34015240-3439DD71-FFCD-44A7-A775-68F501114F2FQ34335807-02930094-3778-489A-B93A-522940C3925AQ34760807-83FA7A4C-5A20-41B6-9925-77E633FA67DCQ35059448-42683F39-1E45-4F4C-8549-FEE4C6B164CBQ35083176-35A8D363-3046-4A44-A16F-FE8EA00871AAQ36341214-5EB4F8C2-CF77-4645-A481-DAC994A5445BQ36787608-4893C4D2-CFFB-476F-AA47-5CC5CF4E4FBFQ36843021-1C71CC5E-C56D-4011-B29D-F4097F35E135Q37274962-C56FB721-7DF1-4DA0-A575-50865EC6AC28Q37279533-FC6ABAA0-56BF-47F4-8025-38210FC5104FQ37450854-B64AE2BE-BDBA-4AD1-9AB0-6FB368C53774Q37522781-88A2AEE5-0FA4-419B-96E8-0BA642E89915Q37686006-C49B7CE5-6946-40AD-8243-E49DA67B9E3DQ38244283-4C557375-BBEB-4DF9-BED6-087AA9701A19Q38260615-53FFBA3B-C810-4407-A21E-4A9B5F83195BQ38357653-B79D6FEC-3F46-4ADF-A786-EA7C15C606C7Q39351138-92D0153C-B9DE-4B1D-B09C-B6078980258BQ41060176-0F4F6B34-9E1C-4184-9B71-72E864E62156Q41504332-D0531E8A-9048-4D98-AD3B-3290524B6778Q42280649-1CB3CB4B-1FBB-4DA7-BFCD-C267A5A51F2FQ55507840-12897072-622B-481C-98B4-945B4A9DCF73Q58710868-0AFA9505-9262-4133-AEAC-0886CF14ED13
P2860
Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development.
@en
Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development.
@nl
type
label
Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development.
@en
Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development.
@nl
prefLabel
Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development.
@en
Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development.
@nl
P2093
P2860
P356
P1433
P1476
Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development.
@en
P2093
Alexander CM
Leatherberry VS
McDermott SP
Ranheim EA
P2860
P2888
P304
P356
10.1038/SJ.ONC.1209930
P407
P577
2006-09-04T00:00:00Z